Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSM1P1 is a pseudogene related to the LSM1 homolog involved in mRNA degradation, named "LSM1 homolog, mRNA degradation associated pseudogene 1." As a pseudogene, it does not produce a functional protein and is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor. Although the functional LSM1 gene is implicated in mRNA degradation and genomic stability, this specific entry—LSM1P1—refers to a non-coding, non-functional sequence, and thus lacks established roles in molecular function, disease, or pharmacology. Key clarifications: - LSM1P1 is a pseudogene and should not be confused with the functional gene "LSM1 homolog, mRNA degradation associated" (abbreviated as LSM1), which does have biological activity in mRNA degradation and genomic stability but is distinct from "LSM1P1". - No evidence supports LSM1P1 as a drug target, biological marker, or disease-related gene in its own right. - If your goal is to describe a therapeutic target, information should focus on the protein-coding LSM1 gene, not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSM1 homolog, mRNA degradation associated pseudogene 1 (LSM1P1).